XAIR
Medical Devices · Healthcare
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when Beyond Air, Inc. publishes a filing, an earnings call transcript or a press release.
Get XAIR alertsDan Moorhead is recorded as CFO at Beyond Air, Inc. (XAIR). Beyond Air, Inc. reported in an 8-K filed December 30, 2025 that Dan Moorhead was appointed Chief Financial Officer, effective January 5, 2026. Dan Moorhead has spoken on 2 earnings calls across 1 company, most recently for Beyond Air, Inc. on June 26, 2026. Beyond Air, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Beyond Air, Inc. includes Robert Goodman (CEO and Board Member), Robert S. Goodman (CEO and Board Member), Robert F. Carey (Chairman) and 7 others.
“Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives of patients, today announced the appointment of Dan Moorhead as Chief Financial Officer, effective January 5, 2026.”
“I'll walk through our full-year financial results for the fiscal year 2026, which ended March 31, 2026. Revenues for the fiscal year ended March 31, 2026 increased 107% to $7.7 million compared with $3.7 million for fiscal year 2025.”
“I'm excited to join my first call since being appointed CFO about seven weeks ago. I still have a lot to learn, but I'm incredibly impressed by what the team has achieved, not just over the past year, but even within the past few months.”
XAIR
Medical Devices · Healthcare
CFO